Enaltus (US rights to BioCorneum)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Rights of a pharmaceutical product. The asset includes distribution rights for BioCorneum, an advanced silicone gel scar management products of the company Enaltus in the United States. The product is a quick drying, patented silicone gel that creates an invisible, breathable, flexible, and waterproof silicone sheet over scars.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- United States
Enaltus (US rights to BioCorneum) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Enaltus (US rights to BioCorneum)‘s full profile, request access.
Request full access to PitchBookEnaltus (US rights to BioCorneum) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Enaltus (US rights to BioCorneum)‘s full profile, request access.
Request full access to PitchBook